PL4071143T3 - Krystaliczna postać monohydratu fumaranu dimetyloaminomicheliolidu - Google Patents

Krystaliczna postać monohydratu fumaranu dimetyloaminomicheliolidu

Info

Publication number
PL4071143T3
PL4071143T3 PL20926506.5T PL20926506T PL4071143T3 PL 4071143 T3 PL4071143 T3 PL 4071143T3 PL 20926506 T PL20926506 T PL 20926506T PL 4071143 T3 PL4071143 T3 PL 4071143T3
Authority
PL
Poland
Prior art keywords
crystalline form
fumarate monohydrate
micheliolide
dimethylamino
dimethylamino micheliolide
Prior art date
Application number
PL20926506.5T
Other languages
English (en)
Inventor
Zhonghua Li
Junbo GONG
Baohong HOU
Songgu WU
Yue Chen
Chuanjiang QIU
Xinghua ZHU
Jie Qi
Guiyan WANG
Original Assignee
Accendatech Co., Ltd.
Nankai University
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Accendatech Co., Ltd., Nankai University filed Critical Accendatech Co., Ltd.
Publication of PL4071143T3 publication Critical patent/PL4071143T3/pl

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/34—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having five-membered rings with one oxygen as the only ring hetero atom, e.g. isosorbide
    • A61K31/343—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having five-membered rings with one oxygen as the only ring hetero atom, e.g. isosorbide condensed with a carbocyclic ring, e.g. coumaran, bufuralol, befunolol, clobenfurol, amiodarone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/365—Lactones
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/4841—Filling excipients; Inactive ingredients
    • A61K9/4866—Organic macromolecular compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A61P35/02—Antineoplastic agents specific for leukemia
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C57/00—Unsaturated compounds having carboxyl groups bound to acyclic carbon atoms
    • C07C57/02—Unsaturated compounds having carboxyl groups bound to acyclic carbon atoms with only carbon-to-carbon double bonds as unsaturation
    • C07C57/13—Dicarboxylic acids
    • C07C57/15—Fumaric acid
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D307/00—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
    • C07D307/77—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom ortho- or peri-condensed with carbocyclic rings or ring systems
    • C07D307/93—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom ortho- or peri-condensed with carbocyclic rings or ring systems condensed with a ring other than six-membered
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07B—GENERAL METHODS OF ORGANIC CHEMISTRY; APPARATUS THEREFOR
    • C07B2200/00—Indexing scheme relating to specific properties of organic compounds
    • C07B2200/07—Optical isomers
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07B—GENERAL METHODS OF ORGANIC CHEMISTRY; APPARATUS THEREFOR
    • C07B2200/00—Indexing scheme relating to specific properties of organic compounds
    • C07B2200/13—Crystalline forms, e.g. polymorphs
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Epidemiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Oncology (AREA)
  • Hematology (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
PL20926506.5T 2020-03-26 2020-03-26 Krystaliczna postać monohydratu fumaranu dimetyloaminomicheliolidu PL4071143T3 (pl)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
PCT/CN2020/081349 WO2021189343A1 (zh) 2020-03-26 2020-03-26 一种含笑内酯二甲基胺富马酸盐的水合物、其制备方法和用途

Publications (1)

Publication Number Publication Date
PL4071143T3 true PL4071143T3 (pl) 2025-08-04

Family

ID=77891524

Family Applications (1)

Application Number Title Priority Date Filing Date
PL20926506.5T PL4071143T3 (pl) 2020-03-26 2020-03-26 Krystaliczna postać monohydratu fumaranu dimetyloaminomicheliolidu

Country Status (12)

Country Link
US (1) US12319666B2 (pl)
EP (1) EP4071143B1 (pl)
JP (1) JP7591224B2 (pl)
KR (1) KR102834850B1 (pl)
AU (1) AU2020437428B2 (pl)
DK (1) DK4071143T3 (pl)
ES (1) ES3034503T3 (pl)
FI (1) FI4071143T3 (pl)
IL (1) IL295869A (pl)
PL (1) PL4071143T3 (pl)
PT (1) PT4071143T (pl)
WO (1) WO2021189343A1 (pl)

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR101421140B1 (ko) 2010-04-23 2014-07-18 난카이 유니버시티 메킬리아 락톤 유도체, 그 약제학적 조성물 및 그 제조방법과 용도
CN103724307B (zh) * 2012-10-12 2015-08-05 天津尚德药缘科技有限公司 含笑内酯二甲基胺富马酸盐的晶型及制备方法
WO2015006893A1 (zh) 2013-07-15 2015-01-22 天津尚德药缘科技有限公司 倍半萜内酯类化合物及其衍生物在制备药物中的用途
CN104876899A (zh) 2014-02-28 2015-09-02 天津尚德药缘科技股份有限公司 二甲胺含笑内酯富马酸盐及其用途
PL3320901T3 (pl) 2016-01-28 2020-07-13 Accendatech Dimetyloaminomicheliolid do zastosowania w leczeniu włóknienia płuc
CN111303099B (zh) * 2018-12-12 2022-12-02 天津尚德药缘科技股份有限公司 含笑内酯二甲基胺富马酸盐晶型f及其制备方法
CN111303097B (zh) * 2018-12-12 2022-09-30 天津尚德药缘科技股份有限公司 二甲胺含笑内酯富马酸盐晶型c及其制备方法
CN111303098B (zh) * 2018-12-12 2022-10-04 天津尚德药缘科技股份有限公司 一种含笑内酯二甲基胺富马酸盐晶型e及其制备方法
CN111303100B (zh) 2018-12-12 2022-10-04 天津尚德药缘科技股份有限公司 一种含笑内酯二甲基胺富马酸盐的水合物、其制备方法和用途

Also Published As

Publication number Publication date
KR102834850B1 (ko) 2025-07-15
WO2021189343A1 (zh) 2021-09-30
EP4071143A4 (en) 2023-01-11
KR20220130212A (ko) 2022-09-26
AU2020437428B2 (en) 2024-03-28
US12319666B2 (en) 2025-06-03
DK4071143T3 (da) 2025-07-07
EP4071143B1 (en) 2025-04-09
AU2020437428A1 (en) 2022-09-15
PT4071143T (pt) 2025-06-30
CA3164892A1 (en) 2021-09-30
FI4071143T3 (fi) 2025-06-26
JP7591224B2 (ja) 2024-11-28
ES3034503T3 (en) 2025-08-19
IL295869A (en) 2022-10-01
EP4071143A1 (en) 2022-10-12
US20230089334A1 (en) 2023-03-23
JP2023522792A (ja) 2023-05-31

Similar Documents

Publication Publication Date Title
IL316075A (en) Crystalline form of lenifranor
IL315411A (en) Pure forms of crystalline eticarpant
HUE067428T2 (hu) 5-MEO-DMT kristályos hidrobromidsója
EP4110786A4 (en) CRYSTALLINE BIS-MIPROCIN FUMARATE
GB202204778D0 (en) Novel crystalline salt forms of mesembrine
IL321053A (en) Crystalline forms of HER2 inhibitor
IL288484A (en) Crystalline salt forms of a kinase inhibitor
GB202102360D0 (en) Crystalline compound
IL281168A (en) Crystal forms of the quinazole compound and its hydrochloride salts
IL321171A (en) Crystalline forms of 2-oxoquinazoline
IL325727A (en) Crystalline form
IL299031A (en) Production of pharmaceutical pure crystals
GB202005114D0 (en) Crystalline Forms of a Pharmaceutical Compound
CA222994S (en) Towel holder
LT4615820T (lt) Kristalinės evenamido formos
IL309311A (en) Synthetic preparation for diroxymal fumarate
GB202009218D0 (en) Crystalline forms of entrectinib
GB202002054D0 (en) Crystalline forms of entrectinib
GB201912411D0 (en) Crystalline forms of ivosidenib
CA3308253A1 (en) Crystalline forms of fumarate salt of mrtx0902
EP3917881C0 (de) Maskierung von kristallinem siliciumdioxid
GB202316444D0 (en) Salts of opicapone
DK4071143T3 (da) Krystallinsk form af dimethylamin micheliolid fumarat monohydrat
GB202317989D0 (en) Novel crystalline salt forms
CA236679S (en) Towel holder